News Focus
News Focus
icon url

genisi

11/11/13 9:37 AM

#169754 RE: DewDiligence #160882

PTLA reports phase II poc study of PRT4445 as Xarelto antidote:

http://investors.portola.com/phoenix.zhtml?c=198136&p=irol-newsArticle&ID=1874725&highlight=